Sylvie Garneau-Tsodikova
From Wikipedia, the free encyclopedia
University of Alberta
Sylvie Garneau-Tsodikova | |
|---|---|
| Alma mater | Université Laval University of Alberta |
| Scientific career | |
| Institutions | Harvard Medical School University of Michigan University of Kentucky |
| Thesis | New antimicrobial agents acting on bacterial cell walls. (2003) |
Sylvie Garneau-Tsodikova is a French Canadian-American chemist who is a Professor and Associate Vice President for Research at the University of Kentucky. One of the areas of her research interest is the development of new molecules to combat bacterial and fungal resistance.
Garneau-Tsodikova was born in Quebec City, Canada. She attended the Université Laval for her undergraduate studies in chemistry, where she graduated top of the class.[1] As a student, she was honoured with several awards, including distinguishments from the Chemical Institute of Canada and Natural Sciences and Engineering Research Council.[1] She completed a Master's thesis on the synthesis of glutamyl transfer RNA synthetase inhibitors.[2] She moved to the University of Alberta for graduate studies, where she worked on the impact of antimicrobial agents of bacterial cell walls.[3][4] During her doctoral studies she became interested in infectious diseases and the development of antibacterial agents.[5]
